Multiparametric Immune Profiles and Their Potential Role in HIV-1 Disease Progression and Treatment
Pathogens · 2025
DOI: 10.3390/pathogens14040347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Junwei Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center f…. Hauptthemen laut MEDLINE: HIV Infections, HIV-1. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Backgrounds: The rapid initiation of highly active anti-retroviral therapy (HAART) can control HIV-1 viremia and stabilize the long-term health of people living with HIV-1 (PLWH). Despite this, individuals who are diagnosed late and exhibit poor therapeutic efficacy still pose a great challenge to global HIV management. To address this, we conducted comprehensive multiparametric immune profiling and analyzed its association with disease progression and therapeutic efficacy.
Methods
Multicolor flow cytometry was used to characterize the circulating immune cell composition and cellular phenotypes in 40 treatment-naive individuals (16 chronic, 24 newly diagnosed), 26 HAART-treated individuals, and 18 healthy controls. Comparative analyses of T cell subsets, immune activation markers, and viral load signatures were performed, followed by network construction. We carried out principal component analysis and displayed the data by dimensionality reduction.
Results
Persistent immune activation, dysregulated regulatory immunity, and aberrant memory differentiation markers were identified in T cells of HIV-1-infected individuals and were associated with disease progression. Additionally, HAART-treated patients which did not fully restore CD4 T cells exhibited higher levels of activated markers, suggesting possible biomarkers of therapeutic efficacy.
Conclusions
This study describes changes in immune cell profiles throughout HIV-1 disease progression and explores suitable laboratory predictors for future clinical and therapeutic settings by monitoring pathological immune cell events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Infectious Diseases, State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for the Diagnosis and Treatment of Infectious Diseases, National Clinic…
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
ORCID-Profile: Junjie Zhang, Dan Li
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key R&D Program of China
Zitieren
APA
Su, J., Zhang, J., Wang, Q., Liu, X., Wang, S., Ruan, Y., & Li, D. (2025). Multiparametric Immune Profiles and Their Potential Role in HIV-1 Disease Progression and Treatment. Pathogens. https://doi.org/10.3390/pathogens14040347
Vancouver
Su J, Zhang J, Wang Q, Liu X, Wang S, Ruan Y, et al. Multiparametric Immune Profiles and Their Potential Role in HIV-1 Disease Progression and Treatment. Pathogens. 2025. doi:10.3390/pathogens14040347
BibTeX
@article{Su2025,
author = {Su, Junwei and Zhang, Junjie and Wang, Qianying and Liu, Xiaojing and Wang, Shuo and Ruan, Yuhua and Li, Dan},
title = {Multiparametric Immune Profiles and Their Potential Role in HIV-1 Disease Progression and Treatment},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14040347}
}
EUVIMED